[1]
Sigwart U,Puel J,Mirkovitch V,Joffre F,Kappenberger L, Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. The New England journal of medicine. 1987 Mar 19 [PubMed PMID: 2950322]
[4]
Stone GW,Ellis SG,Cox DA,Hermiller J,O'Shaughnessy C,Mann JT,Turco M,Caputo R,Bergin P,Greenberg J,Popma JJ,Russell ME, One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004 Apr 27; [PubMed PMID: 15078803]
[5]
Stone GW,Ellis SG,Cox DA,Hermiller J,O'Shaughnessy C,Mann JT,Turco M,Caputo R,Bergin P,Greenberg J,Popma JJ,Russell ME, A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. The New England journal of medicine. 2004 Jan 15; [PubMed PMID: 14724301]
[6]
Kandzari DE,Leon MB,Meredith I,Fajadet J,Wijns W,Mauri L, Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents. JACC. Cardiovascular interventions. 2013 May; [PubMed PMID: 23602459]
[7]
Leon MB,Mauri L,Popma JJ,Cutlip DE,Nikolsky E,O'Shaughnessy C,Overlie PA,McLaurin BT,Solomon SL,Douglas JS Jr,Ball MW,Caputo RP,Jain A,Tolleson TR,Reen BM 3rd,Kirtane AJ,Fitzgerald PJ,Thompson K,Kandzari DE, A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. Journal of the American College of Cardiology. 2010 Feb 9; [PubMed PMID: 20152559]
[8]
Mauri L,Massaro JM,Jiang S,Meredith I,Wijns W,Fajadet J,Kandzari DE,Leon MB,Cutlip DE,Thompson KP, Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents. JACC. Cardiovascular interventions. 2010 Dec; [PubMed PMID: 21232717]
[9]
Simard T,Hibbert B,Ramirez FD,Froeschl M,Chen YX,O'Brien ER, The evolution of coronary stents: a brief review. The Canadian journal of cardiology. 2014 Jan; [PubMed PMID: 24286961]
[10]
Eberhart RC,Su SH,Nguyen KT,Zilberman M,Tang L,Nelson KD,Frenkel P, Bioresorbable polymeric stents: current status and future promise. Journal of biomaterials science. Polymer edition. 2003; [PubMed PMID: 12747671]
[11]
Schwartz RS,Huber KC,Murphy JG,Edwards WD,Camrud AR,Vlietstra RE,Holmes DR, Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. Journal of the American College of Cardiology. 1992 Feb [PubMed PMID: 1732351]
[12]
Hoffmann R,Mintz GS,Dussaillant GR,Popma JJ,Pichard AD,Satler LF,Kent KM,Griffin J,Leon MB, Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation. 1996 Sep 15; [PubMed PMID: 8822976]
[13]
Ross R,Glomset J,Harker L, Response to injury and atherogenesis. The American journal of pathology. 1977 Mar; [PubMed PMID: 842616]
[14]
Tung R,Kaul S,Diamond GA,Shah PK, Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence. Annals of internal medicine. 2006 Jun 20 [PubMed PMID: 16785479]
[15]
Lüscher TF,Steffel J,Eberli FR,Joner M,Nakazawa G,Tanner FC,Virmani R, Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007 Feb 27; [PubMed PMID: 17325255]
[16]
Abbott JD, Revealing the silver and red lining in drug-eluting stents with angioscopy. Circulation. Cardiovascular interventions. 2008 Aug; [PubMed PMID: 20031649]
[17]
Finn AV,Nakazawa G,Joner M,Kolodgie FD,Mont EK,Gold HK,Virmani R, Vascular responses to drug eluting stents: importance of delayed healing. Arteriosclerosis, thrombosis, and vascular biology. 2007 Jul; [PubMed PMID: 17510464]
[18]
Lee CW,Park DW,Lee BK,Kim YH,Hong MK,Kim JJ,Park SW,Park SJ, Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries. The American journal of cardiology. 2006 Feb 15; [PubMed PMID: 16461047]
[19]
Iakovou I,Schmidt T,Bonizzoni E,Ge L,Sangiorgi GM,Stankovic G,Airoldi F,Chieffo A,Montorfano M,Carlino M,Michev I,Corvaja N,Briguori C,Gerckens U,Grube E,Colombo A, Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005 May 4; [PubMed PMID: 15870416]
[21]
Sourgounis A,Lipiecki J,Lo TS,Hamon M, Coronary stents and chronic anticoagulation. Circulation. 2009 Mar 31; [PubMed PMID: 19332481]
[22]
Otsuka Y,Saito S,Nakamura M,Shuto H,Mitsudo K, Comparison of pharmacokinetics of the limus-eluting stents in Japanese patients. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography [PubMed PMID: 21538783]
[23]
Chhatriwalla AK,Cam A,Unzek S,Bhatt DL,Raymond RE,Lincoff AM,Whitlow PL,Ellis SG,Tuzcu EM,Kapadia SR, Drug-eluting stent fracture and acute coronary syndrome. Cardiovascular revascularization medicine : including molecular interventions. 2009 Jul-Sep; [PubMed PMID: 19595398]
[24]
Aoki J,Nakazawa G,Tanabe K,Hoye A,Yamamoto H,Nakayama T,Onuma Y,Higashikuni Y,Otsuki S,Yagishita A,Yachi S,Nakajima H,Hara K, Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography [PubMed PMID: 17195199]
[25]
Park KW,Park JJ,Chae IH,Seo JB,Yang HM,Lee HY,Kang HJ,Cho YS,Yeon TJ,Chung WY,Koo BK,Choi DJ,Oh BH,Park YB,Kim HS, Clinical characteristics of coronary drug-eluting stent fracture: insights from a two-center des registry. Journal of Korean medical science. 2011 Jan; [PubMed PMID: 21218030]
[26]
Everett KD,Conway C,Desany GJ,Baker BL,Choi G,Taylor CA,Edelman ER, Structural Mechanics Predictions Relating to Clinical Coronary Stent Fracture in a 5 Year Period in FDA MAUDE Database. Annals of biomedical engineering. 2016 Feb; [PubMed PMID: 26467552]
[27]
Conway C, Coronary Stent Fracture: Clinical Evidence Vs. the Testing Paradigm. Cardiovascular engineering and technology. 2018 Dec; [PubMed PMID: 30341730]
[28]
Cook S,Wenaweser P,Togni M,Billinger M,Morger C,Seiler C,Vogel R,Hess O,Meier B,Windecker S, Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007 May 8; [PubMed PMID: 17485593]
[29]
Hong MK,Mintz GS,Lee CW,Park DW,Park KM,Lee BK,Kim YH,Song JM,Han KH,Kang DH,Cheong SS,Song JK,Kim JJ,Park SW,Park SJ, Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006 Jan 24; [PubMed PMID: 16432073]
[30]
Butany J,Carmichael K,Leong SW,Collins MJ, Coronary artery stents: identification and evaluation. Journal of clinical pathology. 2005 Aug; [PubMed PMID: 16049279]
[31]
Bertrand OF,Sipehia R,Mongrain R,Rodés J,Tardif JC,Bilodeau L,Côté G,Bourassa MG, Biocompatibility aspects of new stent technology. Journal of the American College of Cardiology. 1998 Sep [PubMed PMID: 9741494]
[32]
Abizaid A,Popma JJ,Tanajura LF,Hattori K,Solberg B,Larracas C,Feres F,Costa Jde R Jr,Schwartz LB, Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography [PubMed PMID: 18044791]
[33]
Hamm CW,Beythien C,Sievert H,Langer A,Utech A,Terres W,Reifart N, Multicenter evaluation of the Strecker tantalum stent for acute coronary occlusion after angioplasty. American heart journal. 1995 Mar [PubMed PMID: 7872165]
[34]
Scott NA,Robinson KA,Nunes GL,Thomas CN,Viel K,King SB 3rd,Harker LA,Rowland SM,Juman I,Cipolla GD, Comparison of the thrombogenicity of stainless steel and tantalum coronary stents. American heart journal. 1995 May; [PubMed PMID: 7732974]
[35]
Stoeckel D,Pelton A,Duerig T, Self-expanding nitinol stents: material and design considerations. European radiology. 2004 Feb [PubMed PMID: 12955452]
[36]
Milewski K,Zurakowski A,Pajak J,Pajak-Zielinska E,Liszka L,Buszman PP,Bis J,Debinski M,Buszman PE, Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia. Medical science monitor : international medical journal of experimental and clinical research. 2010 Jan; [PubMed PMID: 20037484]
[37]
Menown IB,Noad R,Garcia EJ,Meredith I, The platinum chromium element stent platform: from alloy, to design, to clinical practice. Advances in therapy. 2010 Mar; [PubMed PMID: 20437213]
[38]
Koh AS,Choi LM,Sim LL,Tan JW,Khin LW,Chua TS,Koh TH,Chia S, Comparing the use of cobalt chromium stents to stainless steel stents in primary percutaneous coronary intervention for acute myocardial infarction: a prospective registry. Acute cardiac care. 2011 Dec [PubMed PMID: 22142201]
[39]
Abreu Filho LM,Forte AA,Sumita MK,Favarato D,Meireles GC, Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease. Clinics (Sao Paulo, Brazil). 2011 [PubMed PMID: 21808863]
[40]
Youssef AA,Hussein H,Hsueh SK,Chen CJ,Yang CH,Hang CL,Hsieh YK,Fang CY,Yip HK,Wu CJ, Cobalt chromium coronary stents and drug-eluting stents in real practice. International heart journal. 2010 Jul [PubMed PMID: 20716838]
[41]
Jorge C,Dubois C, Clinical utility of platinum chromium bare-metal stents in coronary heart disease. Medical devices (Auckland, N.Z.). 2015 [PubMed PMID: 26345228]
[42]
Zahedmanesh H,Lally C, Determination of the influence of stent strut thickness using the finite element method: implications for vascular injury and in-stent restenosis. Medical [PubMed PMID: 19189146]
[43]
Kastrati A,Mehilli J,Dirschinger J,Dotzer F,Schühlen H,Neumann FJ,Fleckenstein M,Pfafferott C,Seyfarth M,Schömig A, Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation. 2001 Jun 12; [PubMed PMID: 11401938]
[44]
Slodownik D,Danenberg C,Merkin D,Swaid F,Moshe S,Ingber A,Lotan H,Durst R, Coronary stent restenosis and the association with allergy to metal content of 316L stainless steel. Cardiovascular journal of Africa. 2018 Jan/Feb 23 [PubMed PMID: 29443350]
[45]
Gong Z,Li M,Guo X,Ma Z,Shi J, Stent implantation in patients with metal allergy: a systemic review and meta-analysis. Coronary artery disease. 2013 Dec [PubMed PMID: 24135817]
[46]
Romero-Brufau S,Best PJ,Holmes DR Jr,Mathew V,Davis MD,Sandhu GS,Lennon RJ,Rihal CS,Gulati R, Outcomes after coronary stent implantation in patients with metal allergy. Circulation. Cardiovascular interventions. 2012 Apr; [PubMed PMID: 22456027]
[47]
Gurbel PA,Callahan KP,Malinin AI,Serebruany VL,Gillis J, Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) Study. The Journal of invasive cardiology. 2002 Oct; [PubMed PMID: 12368510]
[48]
Dziewierz A,Dudek D, Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease. Kardiologia polska. 2018; [PubMed PMID: 30251247]
[49]
Hoffmann R,Jansen C,König A,Haager PK,Kerckhoff G,vom Dahl J,Klauss V,Hanrath P,Mudra H, Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study. European heart journal. 2001 Nov; [PubMed PMID: 11603908]
[50]
Welt FG,Rogers C, Inflammation and restenosis in the stent era. Arteriosclerosis, thrombosis, and vascular biology. 2002 Nov 1; [PubMed PMID: 12426203]
[51]
Haase J,Störger H,Hofmann M,Schwarz CE,Reinemer H,Schwarz F, Comparison of stainless steel stents coated with turbostratic carbon and uncoated stents for percutaneous coronary interventions. The Journal of invasive cardiology. 2003 Oct; [PubMed PMID: 14519887]
[52]
Finn AV,Joner M,Nakazawa G,Kolodgie F,Newell J,John MC,Gold HK,Virmani R, Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007 May 8; [PubMed PMID: 17438147]
[53]
Moravej M,Mantovani D, Biodegradable metals for cardiovascular stent application: interests and new opportunities. International journal of molecular sciences. 2011 [PubMed PMID: 21845076]
[54]
Gundogan B,Tan A,Farhatnia Y,Alavijeh MS,Cui Z,Seifalian AM, Bioabsorbable stent quo vadis: a case for nano-theranostics. Theranostics. 2014 [PubMed PMID: 24672583]
[55]
Stone GW,Ellis SG,Cannon L,Mann JT,Greenberg JD,Spriggs D,O'Shaughnessy CD,DeMaio S,Hall P,Popma JJ,Koglin J,Russell ME, Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005 Sep 14 [PubMed PMID: 16160130]
[56]
Chatterjee S,Pandey A, Drug eluting stents: friend or foe? A review of cellular mechanisms behind the effects of Paclitaxel and sirolimus eluting stents. Current drug metabolism. 2008 Jul; [PubMed PMID: 18680476]
[57]
Marks AR, Sirolimus for the prevention of in-stent restenosis in a coronary artery. The New England journal of medicine. 2003 Oct 2; [PubMed PMID: 14523135]
[59]
Levin AD,Jonas M,Hwang CW,Edelman ER, Local and systemic drug competition in drug-eluting stent tissue deposition properties. Journal of controlled release : official journal of the Controlled Release Society. 2005 Dec 5; [PubMed PMID: 16289420]
[60]
Wessely R,Schömig A,Kastrati A, Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. Journal of the American College of Cardiology. 2006 Feb 21; [PubMed PMID: 16487832]
[61]
Papafaklis MI,Bourantas CV,Theodorakis PE,Katsouras CS,Naka KK,Fotiadis DI,Michalis LK, The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans. JACC. Cardiovascular interventions. 2010 Nov; [PubMed PMID: 21087755]
[62]
Cole OJ,Shehata M,Rigg KM, Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model. Transplantation proceedings. 1998 Aug; [PubMed PMID: 9723440]
[63]
Baetta R,Granata A,Canavesi M,Ferri N,Arnaboldi L,Bellosta S,Pfister P,Corsini A, Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits. The Journal of pharmacology and experimental therapeutics. 2009 Feb; [PubMed PMID: 19023042]
[64]
Kandzari DE,Smits PC,Love MP,Ben-Yehuda O,Banai S,Robinson SD,Jonas M,Kornowski R,Bagur R,Iniguez A,Danenberg H,Feldman R,Jauhar R,Chandna H,Parikh M,Perlman GY,Balcells M,Markham P,Ozan MO,Genereux P,Edelman ER,Leon MB,Stone GW, Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis). Circulation. 2017 Oct 3; [PubMed PMID: 28794001]
[65]
Camici GG,Steffel J,Amanovic I,Breitenstein A,Baldinger J,Keller S,Lüscher TF,Tanner FC, Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. European heart journal. 2010 Jan; [PubMed PMID: 19567381]
[66]
Huang Y,Venkatraman SS,Boey FY,Lahti EM,Umashankar PR,Mohanty M,Arumugam S,Khanolkar L,Vaishnav S, In vitro and in vivo performance of a dual drug-eluting stent (DDES). Biomaterials. 2010 May; [PubMed PMID: 20189244]
[67]
Kang SN,Kim SE,Choi J,Park K,Goo JH,Sim DS,Hong YJ,Kim JH,Joung YK,Lee J,Jeong MH,Han DK, Comparison of phytoncide with sirolimus as a novel drug candidate for drug-eluting stent. Biomaterials. 2015 Mar [PubMed PMID: 25617121]
[68]
Macdonald RG,Panush RS,Pepine CJ, Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty. The American journal of cardiology. 1987 Jul 31; [PubMed PMID: 2956845]
[69]
Meyer Zu Schwabedissen HE,Begunk R,Hussner J,Juhnke BO,Gliesche D,Böttcher K,Sternberg K,Schmitz KP,Kroemer HK, Cell-specific expression of uptake transporters--a potential approach for cardiovascular drug delivery devices. Molecular pharmaceutics. 2014 Mar 3; [PubMed PMID: 24495124]
[70]
Lee JJ,Lee JH,Yim NH,Han JH,Ma JY, Application of galangin, an active component of Alpinia officinarum Hance (Zingiberaceae), for use in drug-eluting stents. Scientific reports. 2017 Aug 15; [PubMed PMID: 28811550]
[71]
Hamada N,Miyata M,Eto H,Shirasawa T,Akasaki Y,Nagaki A,Tei C, Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model. Atherosclerosis. 2010 Jan; [PubMed PMID: 19682688]
[72]
Siller-Matula JM,Tentzeris I,Vogel B,Schacherl S,Jarai R,Geppert A,Unger G,Huber K, Tacrolimus-eluting carbon-coated stents versus sirolimus-eluting stents for prevention of symptom-driven clinical end points. Clinical research in cardiology : official journal of the German Cardiac Society. 2010 Oct; [PubMed PMID: 20405134]
[73]
Oh B,Melchert RB,Lee CH, Biomimicking Robust Hydrogel for the Mesenchymal Stem Cell Carrier. Pharmaceutical research. 2015 Oct; [PubMed PMID: 25911596]
[74]
Serruys PW,Ormiston JA,Sianos G,Sousa JE,Grube E,den Heijer P,de Feyter P,Buszman P,Schömig A,Marco J,Polonski L,Thuesen L,Zeiher AM,Bett JH,Suttorp MJ,Glogar HD,Pitney M,Wilkins GT,Whitbourn R,Veldhof S,Miquel K,Johnson R,Coleman L,Virmani R, Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. Journal of the American College of Cardiology. 2004 Oct 6; [PubMed PMID: 15464314]
[75]
Acharya G,Park K, Mechanisms of controlled drug release from drug-eluting stents. Advanced drug delivery reviews. 2006 Jun 3; [PubMed PMID: 16546289]
[76]
Rizas KD,Mehilli J, Stent Polymers: Do They Make a Difference? Circulation. Cardiovascular interventions. 2016 Jun; [PubMed PMID: 27193905]
[78]
Kastrati A,Schömig A,Dirschinger J,Mehilli J,von Welser N,Pache J,Schühlen H,Schilling T,Schmitt C,Neumann FJ, Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation. 2000 May 30; [PubMed PMID: 10831521]
[79]
Pinchuk L,Wilson GJ,Barry JJ,Schoephoerster RT,Parel JM,Kennedy JP, Medical applications of poly(styrene-block-isobutylene-block-styrene) ( [PubMed PMID: 17980425]
[80]
Busch R,Strohbach A,Rethfeldt S,Walz S,Busch M,Petersen S,Felix S,Sternberg K, New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets. Acta biomaterialia. 2014 Feb; [PubMed PMID: 24148751]
[81]
Tyler B,Gullotti D,Mangraviti A,Utsuki T,Brem H, Polylactic acid (PLA) controlled delivery carriers for biomedical applications. Advanced drug delivery reviews. 2016 Dec 15; [PubMed PMID: 27426411]
[82]
Jain RA, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials. 2000 Dec; [PubMed PMID: 11055295]
[83]
Sung HJ,Meredith C,Johnson C,Galis ZS, The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials. 2004 Nov; [PubMed PMID: 15147819]
[84]
Xi T,Gao R,Xu B,Chen L,Luo T,Liu J,Wei Y,Zhong S, In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents. Biomaterials. 2010 Jul; [PubMed PMID: 20382420]
[85]
Pilgrim T,Windecker S, Drug-eluting stent technology: progress beyond the polymer. European heart journal. 2014 Aug 7; [PubMed PMID: 24908391]
[86]
Han Y,Xu B,Jing Q,Lu S,Yang L,Xu K,Li Y,Li J,Guan C,Kirtane AJ,Yang Y, A randomized comparison of novel biodegradable polymer- and durable polymer-coated cobalt-chromium sirolimus-eluting stents. JACC. Cardiovascular interventions. 2014 Dec; [PubMed PMID: 25440887]
[87]
Hausleiter J,Kastrati A,Mehilli J,Schühlen H,Pache J,Dotzer F,Sattelberger U,Dirschinger J,Schömig A, Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial. American heart journal. 2003 Nov; [PubMed PMID: 14597939]
[88]
Nakazawa G,Finn AV,John MC,Kolodgie FD,Virmani R, The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents. The American journal of cardiology. 2007 Oct 22; [PubMed PMID: 17950831]
[89]
Granada JF,Huibregtse BA,Dawkins KD, New stent design for use in small coronary arteries during percutaneous coronary intervention. Medical devices (Auckland, N.Z.). 2010; [PubMed PMID: 22915922]
[90]
Lee JZ,Singh N,Ortega G,Low SW,Kanakadandi U,Fortuin FD,Lassar T,Lee KS, Composite outcomes in 2.25-mm drug eluting stents: a systematic review. Cardiovascular revascularization medicine : including molecular interventions. 2015 Jun; [PubMed PMID: 25976630]
[91]
Marroquin OC,Selzer F,Mulukutla SR,Williams DO,Vlachos HA,Wilensky RL,Tanguay JF,Holper EM,Abbott JD,Lee JS,Smith C,Anderson WD,Kelsey SF,Kip KE, A comparison of bare-metal and drug-eluting stents for off-label indications. The New England journal of medicine. 2008 Jan 24; [PubMed PMID: 18216354]
[92]
Bundhun PK,Bhurtu A,Soogund MZ,Long MY, Comparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials. PloS one. 2016; [PubMed PMID: 27111304]
[93]
Khera S,Villablanca PA,Kolte D,Gupta T,Hasan Khan M,Velagapudi P,Kalra A,Kleiman N,Aronow HD,Abbott JD,Rosenfield K,Drachman DE,Bangalore S,Bhatt DL,Naidu SS, Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis: A Systematic Review and Meta-Analysis. Cardiology in review. 2018 Nov/Dec; [PubMed PMID: 30157064]
[94]
Stone GW,Witzenbichler B,Guagliumi G,Peruga JZ,Brodie BR,Dudek D,Kornowski R,Hartmann F,Gersh BJ,Pocock SJ,Dangas G,Wong SC,Fahy M,Parise H,Mehran R, Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet (London, England). 2011 Jun 25; [PubMed PMID: 21665265]
[95]
Iakovou I,Ge L,Colombo A, Contemporary stent treatment of coronary bifurcations. Journal of the American College of Cardiology. 2005 Oct 18; [PubMed PMID: 16226167]
[96]
Lai CH,Lee WL,Sung SH,Hsu PF,Chen YH,Chan WL,Lin SJ,Lu TM, Comparison of Bare-Metal Stent and Drug-Eluting Stent for the Treatment of Patients Undergoing Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease - Long-Term Result from a Single Center Experience. Acta Cardiologica Sinica. 2015 Sep; [PubMed PMID: 27122897]
[97]
Colombo A,Giannini F,Briguori C, Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory? Journal of the American College of Cardiology. 2017 Aug 1 [PubMed PMID: 28750704]
[98]
Hill RA,Boland A,Dickson R,Dündar Y,Haycox A,McLeod C,Mujica Mota R,Walley T,Bagust A, Drug-eluting stents: a systematic review and economic evaluation. Health technology assessment (Winchester, England). 2007 Nov [PubMed PMID: 17999841]
[99]
Rinfret S,Cohen DJ,Tahami Monfared AA,Lelorier J,Mireault J,Schampaert E, Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2006 [PubMed PMID: 16780389]
[100]
Goeree R,Bowen JM,Blackhouse G,Lazzam C,Cohen E,Chiu M,Hopkins R,Tarride JE,Tu JV, Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario. International journal of technology assessment in health care. 2009 Apr [PubMed PMID: 19331710]
[101]
Kandzari DE,Mauri L,Popma JJ,Turco MA,Gurbel PA,Fitzgerald PJ,Leon MB, Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC. Cardiovascular interventions. 2011 May; [PubMed PMID: 21596327]
[102]
Kalra A,Rehman H,Khera S,Thyagarajan B,Bhatt DL,Kleiman NS,Yeh RW, New-Generation Coronary Stents: Current Data and Future Directions. Current atherosclerosis reports. 2017 Mar [PubMed PMID: 28220461]
[103]
Puranik AS,Dawson ER,Peppas NA, Recent advances in drug eluting stents. International journal of pharmaceutics. 2013 Jan 30 [PubMed PMID: 23117022]
[104]
Lee DH,de la Torre Hernandez JM, The Newest Generation of Drug-eluting Stents and Beyond. European cardiology. 2018 Aug [PubMed PMID: 30310472]